Sandy Balkin is SVP Strategy and Analytics at Royalty Pharma where he is responsible for building and managing a cross-functional team charged with leveraging data to identify and support investment identification and valuation. Prior to joining Royalty Pharma, Sandy was Managing Director and Leader of the Truist Securities’ Data Science and Engineering research team developing capabilities in data science, machine learning and alternative data and integrating them into quantamental investment research. Over his career, he has built and led advanced business analytics functions at top pharmaceutical companies, including Pfizer, Boehringer Ingelheim, and Sanofi.
Sandy has a Ph.D. in Business Administration from Penn State University, a Master of Arts in Statistics from Penn State University, as well as a Bachelor of Arts Degree in Mathematics and Economics and Music from Lafayette College, where he graduated with honors. Sandy currently holds adjunct faculty positions at New York University and Columbia University.